Cerebral Small Vessels Disease Recruiting Phase 2 Trials for Tadalafil (DB00820)

Back to Cerebral Small Vessels Disease

Also known as: Cerebral Small-vessel Disease / Cerebral Small Vessel Disease / Cerebral Small Vessel Diseases / Cerebral microangiopathy / Small vessel cerebrovascular disease (disorder) / Cerebral small vessel ischaemic disease / Cerebral small vessel ischemic disease

IndicationStatusPhase
DBCOND0072196 (Cerebral Small Vessels Disease)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05173896
Improving Cerebral Blood Flow and Cognition in Patients With Cerebral Small Vessel Disease. The ETLAS-2 TrialPrevention